# Electrochemotherapy as a Palliative Treatment for Brain Metastases

> **NCT01322100** · PHASE1 · TERMINATED · sponsor: **Copenhagen University Hospital at Herlev** · enrollment: 1 (actual)

## Conditions studied

- Brain Metastases
- CNS Metastases

## Interventions

- **DEVICE:** The Electroporation System
- **DRUG:** Bleomycin

## Key facts

- **NCT ID:** NCT01322100
- **Lead sponsor:** Copenhagen University Hospital at Herlev
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Due to slow patient recruitment
- **Last updated:** 2013-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322100, "Electrochemotherapy as a Palliative Treatment for Brain Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01322100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*